These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 9834719

  • 1. Routine prenatal screening for HIV in a low-prevalence setting.
    Patrick DM, Money DM, Forbes J, Dobson SR, Rekart ML, Cook DA, Middleton PJ, Burdge DR.
    CMAJ; 1998 Oct 20; 159(8):942-7. PubMed ID: 9834719
    [Abstract] [Full Text] [Related]

  • 2. HIV infection and zidovudine use in childbearing women.
    Sia J, Paul S, Martin RM, Cross H.
    Pediatrics; 2004 Dec 20; 114(6):e707-12. PubMed ID: 15545619
    [Abstract] [Full Text] [Related]

  • 3. Cost-effectiveness of voluntary prenatal and routine newborn HIV screening.
    AIDS Read; 2001 Feb 20; 11(2):81. PubMed ID: 11279876
    [No Abstract] [Full Text] [Related]

  • 4. Economic evaluation of HIV screening in pregnant women attending antenatal clinics in India.
    Kumar M, Birch S, Maturana A, Gafni A.
    Health Policy; 2006 Jul 20; 77(2):233-43. PubMed ID: 16126300
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness estimates for antenatal HIV testing in the Netherlands.
    Rozenbaum MH, Verweel G, Folkerts DK, Dronkers F, van den Hoek JA, Hartwig NG, de Groot R, Postma MJ.
    Int J STD AIDS; 2008 Oct 20; 19(10):668-75. PubMed ID: 18824618
    [Abstract] [Full Text] [Related]

  • 6. Cost-effectiveness of interventions to reduce vertical HIV transmission from pregnant women who have not received prenatal care.
    Mrus JM, Tsevat J.
    Med Decis Making; 2004 Oct 20; 24(1):30-9. PubMed ID: 15005952
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [HIV screening of pregnant women in Norway].
    Reinar LM, Haegeland A, Tollefsen MF, Bjørkeng W.
    Tidsskr Nor Laegeforen; 2000 Jan 20; 120(2):221-4. PubMed ID: 10851920
    [Abstract] [Full Text] [Related]

  • 10. HIV seroprevalence, uptake of interventions to reduce mother-to-child transmission and birth outcomes in greater Kingston, Jamaica.
    Johnson N, Mullings AA, Harvey KM, Alexander G, McDonald D, Smikle MF, Williams E, Palmer P, Whorms S, Figueroa JP, Christie CD.
    West Indian Med J; 2004 Oct 20; 53(5):297-302. PubMed ID: 15675494
    [Abstract] [Full Text] [Related]

  • 11. A study to determine the incidence and prevalence of newly discovered human immunodeficiency virus infection during the prenatal care period.
    Grimes RM, Srivastava G, Helfgott AW, Eriksen NL.
    Infect Dis Obstet Gynecol; 2000 Oct 20; 8(3-4):172-5. PubMed ID: 10968601
    [Abstract] [Full Text] [Related]

  • 12. Preventing perinatal transmission of HIV--costs and effectiveness of a recommended intervention.
    Gorsky RD, Farnham PG, Straus WL, Caldwell B, Holtgrave DR, Simonds RJ, Rogers MF, Guinan ME.
    Public Health Rep; 1996 Oct 20; 111(4):335-41. PubMed ID: 8711101
    [Abstract] [Full Text] [Related]

  • 13. Voluntary screening program for HIV in pregnancy. Cost effectiveness.
    Rivera-Alsina ME, Rivera CC, Rollene N, Kirby RS, Ayres A, McNamara M.
    J Reprod Med; 2001 Mar 20; 46(3):243-8. PubMed ID: 11304866
    [Abstract] [Full Text] [Related]

  • 14. Voluntary counselling and testing (VCT) uptake, nevirapine use and infant feeding options at the University of Nigeria Teaching Hospital.
    Onah HE, Ibeziako N, Nkwo PO, Obi SN, Nwankwo TO.
    J Obstet Gynaecol; 2008 Apr 20; 28(3):276-9. PubMed ID: 18569467
    [Abstract] [Full Text] [Related]

  • 15. Routine screening for HIV infection in booked antenatal women: how justified in developing countries?
    Ibekwe PC, Ikeme AC.
    Afr J Reprod Health; 2001 Aug 20; 5(2):7-9. PubMed ID: 12471908
    [No Abstract] [Full Text] [Related]

  • 16. HIV testing and prevention issues for women attending termination assessment clinics.
    Bergenstrom A, Sherr L.
    Br J Fam Plann; 1999 Apr 20; 25(1):3-8. PubMed ID: 10228241
    [Abstract] [Full Text] [Related]

  • 17. Would universal antenatal screening for HIV infection be cost-effective in a setting of very low prevalence? Modelling the data for Australia.
    Graves N, Walker DG, McDonald AM, Kaldor JM, Ziegler JB.
    J Infect Dis; 2004 Jul 01; 190(1):166-74. PubMed ID: 15195257
    [Abstract] [Full Text] [Related]

  • 18. From research to practice: use of short course zidovudine to prevent mother-to-child HIV transmission in the context of routine health care in Northern Thailand.
    Thaineua V, Sirinirund P, Tanbanjong A, Lallemant M, Soucat A, Lamboray JL.
    Southeast Asian J Trop Med Public Health; 1998 Sep 01; 29(3):429-42. PubMed ID: 10437936
    [Abstract] [Full Text] [Related]

  • 19. An assessment of mother-to-child HIV transmission prevention in 16 pilot antenatal clinics in Jamaica.
    Harvey KM, Figueroa JP, Tomlinson J, Gebre Y, Forbes S, Toyloy T, Thompson T, Thompson K.
    West Indian Med J; 2004 Oct 01; 53(5):293-6. PubMed ID: 15675493
    [Abstract] [Full Text] [Related]

  • 20. Estimating prenatal syphilis and HIV screening rates for commercially insured women.
    Tao G, Patterson E, Lee LM, Sansom S, Teran S, Irwin KL.
    Am J Prev Med; 2005 Feb 01; 28(2):175-81. PubMed ID: 15710273
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.